Edwards Lifesciences Corp. has agreed to pay a six-figure sum plus royalties to Abbott Laboratories to settle claims Edwards infringed on Abbott-held patents on transcatheter mitral and tricuspid repair products.
The settlement announced 13 July dismisses all related court and patent office cases worldwide, as well as the lifting of...